Pallidotomy in advanced Parkinson's disease
Ryan, L.
New England Journal of Medicine 338(4): 262-263 Discusssion 263
1998
ISSN/ISBN: 0028-4793 PMID: 9441239 Document Number: 489925
Document emailed within 1 workday
Related Documents
Sobstyl, M.ł; Zabek, M.ła.; Koziara, H.; Kadziołka, B. 2003: Bilateral pallidotomy for the treatment of advanced Parkinson disease Neurologia i Neurochirurgia Polska 37(Suppl 5): 251-262Kosztolányi, P.ét.; Kállai, J.án.; Balás, I.án.; Karádi, K.áz.ér.; Dóczi, T.ás. 2002: Neuropsychologic outcome after bilateral pallidotomy in patients with Parkinson disease Ideggyogyaszati Szemle 55(7-8): 263-267
Momose, Y.; Murata, M.; Kanazawa, I. 2000: Treatment of advanced Parkinson's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 58(10): 2061-2065
2005: Apomorphine (Apokyn) for advanced Parkinson's Disease Medical Letter on Drugs and Therapeutics 47(1200): 7-8
Béreau, M.; Tomkova, E.; Zacharia, A.é; Bouthour, W.; Fleury, V.; Bally, J.F.ço.; Horvath, J.; Momjian, S.; Lüscher, C.; Burkhard, P.; Krack, P. 2018: Advanced Parkinson's disease : indication for complex treatments Revue Medicale Suisse 14(604): 875-878
Molho, E.S.; Factor, S.A.; Weiner, W.J.; Sanchez-Ramos, J.R.; Singer, C.; Shulman, L.; Brown, D.; Sheldon, C. 1995: The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease Journal of Neural Transmission. Supplementum 45: 225-230
Sage, J.I.; Trooskin, S.; Sonsalla, P.K.; Heikkila, R.E. 1989: Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease Neurology 39(11 Suppl 2: 60
Timofeeva, A.A. 2014: Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 145-151
Fernandez-Pajarin, G.; Ares-Pensado, B.; Sesar, A.; Iglesias-Canle, J.; Masa-Vazquez, L.; Castro, A. 2018: Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease Revista de Neurologia 67(1): 1-5
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Chen, J.; Liu, J.-L.; Chen, X.; Qian, H.; Xian, W.-B.; Zhou, H.-Y.; Liu, Y.-M.; Ye, X.-F.; Zheng, Y.-F.; Zhang, S.-l.; Chen, L.; Li, J.-R.; Liu, Z.-L.; Pei, Z. 2011: Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease Zhonghua Yi Xue Za Zhi 91(5): 291-295
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Mark, M.H.; Sage, J.I. 1989: Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease Annals of Clinical and Laboratory Science 19(2): 101-106
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Sobstyl, M.ł; Zabek, M.ła.; Koziara, H.; Dzierzecki, S. 2009: A patient with parkinsonism related to Gaucher's disease type i successfully treated by unilateral pallidotomy - a 3-year follow-up Neurologia i Neurochirurgia Polska 43(3): 293-297
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Sławek, Jłav.; Friedman, A.; Bogucki, A.; Opala, G. 2007: Stereotactic pallidotomy and thalamotomy in the treatment of primary dystonia Neurologia i Neurochirurgia Polska 41(2): 188-9; Author Reply 190-1
Mastaglia, F.L.; Masters, C.L.; Beyreuther, K.; Kakulas, B.A. 1989: Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease Progress in Clinical and Biological Research 317: 475-484
Schoenberg, B.S. 1987: Descriptive epidemiology of Parkinson's disease: disease distribution and hypothesis formulation Advances in Neurology 45: 277-283
Groves, M.S.; Forrest, D.V. 2005: Parkinson's disease as a model for psychosocial issues in chronic neurodegenerative disease Advances in Neurology 96: 65-83